Research to Practice webinars cover the spectrum of anti-cancer therapy, with a focus on recent research developments, both locally and at large, and what’s ready for regular practice. Perspectives from medical oncology, radiation oncology, and surgery will be included.

The webinar series incorporates an understanding of practice dynamics and concerns throughout the state of North Carolina, and the availability of clinical trials and subspecialty expertise to inform care.

Live Webinars          Self-Paced Online Courses
 

Receive Continuing Education Credits at NO COST
CME • NCPD/CNE • ACPE • ASRT • CTR

Upcoming Live Course

Research to Practice CME • NCPD/CNE • ACPE • ASRT • ODS/CTR   Live Webinar May 28 • 12:00 – 1:00 Advances in the Early Detection of Lung Cancer Jason Akulian, MD, MPH, MBA

Research to Practice CME • NCPD/CNE • ACPE • ASRT • ODS/CTR   Live Webinar June 25 • 12:00 – 1:00 Updates on the Management of Early Stage and Metastatic Breast Cancer Jeffrey Aldrich, MD

Research to Practice CME • NCPD/CNE • ACPE • ASRT • ODS/CTR   Live Webinar July 23 • 12:00 – 1:00 Cancer Immunotherapy Toxicities Identification and Management in North Carolina Rumey Chang Ishizawar, MD, PhD

Research to Practice CME • NCPD/CNE • ACPE • ASRT • ODS/CTR   Live Webinar August 27 • 12:00 – 1:00 CAR-T in North Carolina Natalie Grover, MD

Research to Practice CME • NCPD/CNE • ACPE • ASRT • ODS/CTR   Live Webinar September 24 • 12:00 – 1:00 The Current Management of Pancreatic Cancer Ashwin Somasundaram, MD Ashwin Somasundaram, MD, will focus on the current evidence and guidelines regarding the management and treatment of pancreatic cancer.

Research to Practice CME • NCPD/CNE • ACPE • ASRT • ODS/CTR   Live Webinar October 1 • 12:00 – 1:00 Surgical Oncology in North Carolina Philip Spanheimer, MD, FACS

Research to Practice CME • NCPD/CNE • ACPE • ASRT • ODS/CTR   Live Webinar October 22 • 12:00 – 1:00 Genitourinary Cancer Management in North Carolina Catherine Fahey, MD, PhD

Research to Practice CME • NCPD/CNE • ACPE • ASRT • ODS/CTR   Live Webinar November 19 • 12:00 – 1:00 Radiation Oncology in North Carolina Jean Wright, MD, FASTRO

Research to Practice CME • NCPD/CNE • ACPE • ASRT • ODS/CTR   Live Webinar December 17 • 12:00 – 1:00 Head and Neck Cancer Management in North Carolina Sumita Trivedi, MD

Self-Paced Courses, Online Courses

Research to Practice CME • NCPD/CNE • ACPE • ASRT • ODS/CTR   Available June 14, 2025 – June 13, 2027 Novel Therapeutics for Waldenström Macroglobulinemia Christopher Dittus, DO, MPH Christopher Dittus, DO, MPH, will provide an overview of how to diagnose Waldenstrom Macroglobulinemia (WM) and differentiate it from MGUS and other types of indolent lymphoma. he will discuss potential emergency situations related to hyperviscosity and how to effectively manage this complication. Regarding treatment, Dr. Dittus will discuss standard frontline and relapsed therapy and will review clinical trials evaluating immunotherapy and novel targeted agents.

Research to Practice CME • NCPD/CNE • ACPE • ASRT • ODS/CTR   Available June 13, 2025 – June 12, 2027 Management of Older Adults with AML: Are We Finally Seeing Light at the End of the Tunnel? Joshua Zeidner, MD Overview of diagnosis, biology and management of older adults with AML in 2025

Research to Practice CME • NCPD/CNE • ACPE • ASRT • ODS/CTR   Available March 19, 2025 – March 18, 2027 Update in Bladder Cancer Matthew I. Milowsky, MD, FASCO Matthew I. Milowsky, MD, FASCO, will discuss aspects of bladder cancer including the role of biomarkers in the management of bladder cancer, the role of perioperative therapy for muscle-invasive bladder cancer, and treatment strategies for advanced/metastatic bladder cancer.

Research to Practice CME • NCPD/CNE • ACPE • ASRT • ODS/CTR   Available March 3, 2025 – March 2, 2027 Antibody-Drug Conjugates in Oncology: From Bench to Bedside Kevin Chen, PharmD, MS, BCOP, CPP Antibody drug conjugates have seen a rise in use for the treatment of many different types of cancer. These agents possess a unique mechanism of action different than our prior cancer-directed therapies. Kevin Chen, PharmD, MS, BCOP, CPP, will dive deeper into their structure and pharmacology, key landmark trials highlighting their benefit, and current toxicity challenges limiting their potential, with the goal for attendees to better understand these novel therapeutic agents and incorporate them into their practice.

Research to Practice CME • NCPD/CNE • ACPE • ASRT • ODS/CTR   Available February 13, 2025 – February 12, 2027 Head and Neck Cancer Management in North Carolina Blake Sullivan, MD Over 70,000 people in the United States will be diagnosed with head and neck cancer in 2024. Blake Sullivan, MD, will focus on the impact of head and neck cancer in North Carolina, contemporary treatment strategies available to residents, and future directions.

Research to Practice CME • NCPD/CNE • ACPE • ASRT • ODS/CTR   Available February 10, 2025 – February 9, 2027 Updates in Targeted Therapy for Non-Small Cell Lung Cancer Shetal Patel, MD, PhD Shetal Patel, MD, PhD, will review recently approved treatment strategies for patients with non-small cell lung cancer and targetable genomic alterations.

Research to Practice CME • NCPD/CNE • ACPE • ASRT • ODS/CTR   Available January 20, 2025 – January 19, 2027 Lymphoma Management Updates Anne W. Beaven, MD Anne W. Beaven, MD, will review recent updates and evolving standard of care for management of Hodgkin and Non-Hodgkin lymphoma.

Research to Practice CME • NCPD/CNE • ACPE • ASRT • CTR   Available January 13, 2025 – January 12, 2027 Updates in Surgical Management for Breast Cancer Kristalyn Gallagher, DO, FACOS, FACS Breast cancer management continues to evolve with tailored therapies allowing for a personalized approach to treatment. This is an update on current surgical considerations for breast cancer management.

Research to Practice NCPD/CNE • ACPE • ASRT • ODS/CTR   Available October 9,2024 – October 8, 2026 Management of Multiple Myeloma: Updates Samuel M. Rubinstein, MD, MSCI The management of multiple myeloma is dynamic with a constantly changing landscape. Samuel M. Rubinstein, MD, MSCI, will cover recently published manuscripts and conference presentations that present practice changing data in the management of multiple myeloma

Research to Practice NCPD/CNE • ACPE • ASRT • CTR   Available July 1, 2024 – June 30, 2026 The Selective Use of Radiation in Solid Malignancies Kevin Pearlstein, MD Radiation therapy is an integral part of cancer treatment across many disease sites, but the locoregional control benefits must be weighed against the potential toxicities. During this webinar, Kevin Pearlstein, MD, will review the role of radiation in cancer care including basic radiobiologic principles, logistics, and toxicities. He will discuss several recent studies examining the omission of radiation for different solid malignancies and review strategies to identify patients who will benefit the most from radiation.

Research to Practice NCPD/CNE • ACPE • ASRT • CTR   Available July 3, 2024 – July 2, 2026 Current Concepts in Spinal Oncology Michael Galgano, MD, FAANS Michael Galgano, MD, FAANS, will focus on differentiating the various types of spinal tumors, ranging from metastases, to primary vertebral column tumors, and intradural spinal cord tumors. He will discus the contributions of co-morbidities and frailty on the management of patients with spinal tumors. He will also aim to give the audience a brief exposure to the surgical management of spinal oncology, and what is entailed to execute robust local control.

Research to Practice NCPD/CNE • ACPE • ASRT   Available May 7, 2024 – May 6, 2026 Obesity and Cancer Prevention: The Efficacy and Timing of Bariatric Surgery Maggie M. Hodges, MD, MPH Join Maggie M. Hodges, MD, MPH, for a surgeon's perspective on the role of cancer risk reduction through bariatric surgery, while also exploring the optimal timing of bariatric surgery in patients with a personal history of cancer.

Research to Practice NCPD/CNE • ACPE • ASRT • CTR   Available April 1, 2024 – March 31, 2026 Immune (check point) Related Adverse Events Frances Collichio, MD Frances Collichio, MD, will review the common and uncommon side effects of immune check point inhibitors. She will also discuss the relatively new concept of delayed immune related events.

Research to Practice NCPD/CNE • ACPE • ASRT   Available April 1, 2024 – March 31, 2026 Primary Brain Tumors: Diagnosis and Management Strategies Dominique Higgins, MD, PhD Dominique Higgins, MD, PhD, will provide an overview of diagnostic criteria for primary CNS brain tumors, and the current approved and investigational treatments that are available and on the horizon.

Research to Practice NCPD/CNE • ACPE • ASRT • CTR   Available March 4, 2024 – March 3, 2026 H. Pylori Testing and Treatment for Gastric Cancer Prevention Meira Epplein, PhD Katherine Garman, MD Katherine Garman, MD, and Meira Epplein, PhD, will provide information on gastric cancer and important risk factors such as H. pylori infection. We will describe some of the racial disparities associated with gastric cancer in the US, highlighting those that are relevant for North Carolina. We will also discuss H. pylori as a modifiable risk factor and we will review current guidelines on H. pylori testing, treatment, eradication testing, and the growing problem of antibiotic resistance.

Research to Practice NCPD/CNE • ACPE • ASRT • CTR   Available March 4, 2024 – March 3, 2026 Caring for Older Adults with Acute Leukemia in North Carolina Daniel Richardson, MD, MA, MSc Daniel Richardson, MD, MA, MSc, will explore best practices to approach the care of older adults with leukemia. He will also discuss novel therapeutic options for patients with acute lymphoblastic and acute myeloid leukemia alongside practical considerations to approach shared decision-making.

Research to Practice NCPD/CNE • ACPE • ASRT • CTR   Available February 1, 2024 – January 31, 2026 Update on Prostate Cancer Screening Marc Bjurlin, DO, MSc, FACOS Marc Bjurlin, DO, MSc, FACOS, will give a contemporary overview of prostate cancer screening with a focus on prostate cancer in men in North Carolina.

Research to Practice NCPD/CNE • ACPE • ASRT • CTR   Available February 1, 2024 – January 31, 2026 Genitourinary Cancer Management in North Carolina: Updates for 2023 Hung-Jui (Ray) Tan, MD, MSHPM Hung-Jui Tan, MD, MSHPM, will review recent practice-changing research and new management recommendations for patients with prostate, kidney, bladder, and testicular cancer.

Research to Practice NCPD/CNE • ACPE • ASRT • CTR   Available November 1, 2023 – October 31, 2025 Sarcoma Management in North Carolina: Updates for 2023 Mark Woodcock, MD A broad overview of the multidisciplinary approaches for the treatment of soft tissue sarcomas in adults, and detailed updates in management with systemic therapies. Specific attention is paid to sarcoma sub-types which may warrant special considerations.

Research to Practice NCPD/CNE • ACPE • ASRT • CTR   Available October 2, 2023 – October 1, 2025 Lymphoma Management in North Carolina: Updates for 2023 Natalie Grover, MD Natalie Grover, MD, will review some of the recent advances in the treatment of lymphoma, including the incorporation of novel targeted agents in the frontline treatment of diffuse large B cell lymphoma and Hodgkin lymphoma, the use of CAR-T cell therapy in second-line treatment in diffuse large B cell lymphoma, and recently approved drugs by the FDA for lymphoma.

Research to Practice NCPD/CNE • ACPE • ASRT • CTR   Available September 8, 2023 – September 7, 2025   Radiation Oncology Management of Lung Cancer in NC: Update on Small-Cell Lung Cancer Ashley Weiner, MD, PhD Ashley Weiner, MD, PhD, will focus on the role of radiotherapy for small-cell lung cancer. She will begin with an overview of radiation oncology, then walk through a patient's pathway from initial consultation with a radiation oncologist to treatment and follow-up. Finally, she will review the indications for, logistics of, and side effects of radiation for the treatment of small cell lung cancer (limited and extensive stage).

Research to Practice NCPD/CNE • ACPE • ASRT • CTR   Available July 3, 2023 – July 2, 2025   The Ketogenic Diet for Brain Tumor Patients: A Phase 1 Trial and Beyond... Jethro L. Hu, MD Jethro Hu, MD, will review the rationale and current evidence supporting the potential role of a ketogenic diet for brain tumor patients, focusing on a recently completed phase 1 safety and feasibility trial.